Osteosarcoma
Organised with the support of the Cancer and Bone Society (CABS)
Live Webinar: 9 June 2020, 9am CEST
Date & Time: 9 June 2020, 9am CEST
Featuring David Thomas, Head of the Cancer Theme, Garvan Institute of Medical Research
Moderated by Hanna Taipaleenmäki, ECTS Academy Member.
Costs: Live webinar is free for ECTS members and non-members, but a registration is required.
Recordings are accessible to ECTS members only.
Format:
- 5 min welcome & introductions
- 35 min presentation
- 20 min Q&A
Learning Objectives:
- Osteosarcoma and immunotherapy
- Using human and mouse genetics of sarcomas
- Non-canonical and druggable immune pathways in osteosarcoma
- Paths to clinical trials in rare diseases
Featuring David Thomas
Prof Thomas is Head of the Cancer Theme at the Garvan Institute of Medical Research, and Director of The Kinghorn Cancer Centre. He is a NHMRC Principal Research Fellow and medical oncologist whose focus is on the application of genomic technologies to the understanding and management of cancer. Prof Thomas founded the Australasian Sarcoma Study Group, a national research organisation, and established Australia’s leading adolescent and young adult cancer unit at the Peter MacCallum Cancer Centre.
Dr Thomas leads the International Sarcoma Kindred Study, now recruiting from 23 centres in 7 countries, and led the first international study of denosumab in Giant Cell Tumor of bone, leading to FDA and TGA approval. He has over 150 research publications, including lead or senior author papers in Cancer Cell, Molecular Cell, Journal of Clinical Investigation, Lancet Oncology, JAMA Oncology, and Journal of Clinical Oncology. Since moving to NSW, he has established the Australian Genomic Cancer Medicine Centre, a national precision medicine program for patients with rare and early onset cancers. In 2018, he was President of the Connective Tissue Oncology Society, the peak international body in his field. He has created a national program in genomics medicine – the Australian Genomic Cancer Medicine Program – unifying for the first time the major cancer centres in every state and territory, as well as three of Australia’s leading research organizations (WEHI, Garvan, NHMRC CTC).
